The inspirational value is clear for Lions Health attendees, but there is still confusion about what good looks like for branded pharma campaigns, and how the US fits in.
It's not only a venue to gain creative inspiration, but a good place to scout talent, and there are no lack of strategic meetings underway in Cannes.
The second annual Lions Health creativity festival ended Saturday.
A quarter of this year's 1,862 entries are in the pharma category.
Moore, a longtime Goodwill Ambassador for Unicef, talked with MM&M about how creativity can be used to improve public health.
The Lions Health jurors in 2014 declined to award the top prize in the pharma category, raising questions about how the industry's creativity stacks up against the world's top marketers.
He spoke with MM&M about whether pharma is ready to win a Grand Prix, if regulation limits creativity in healthcare, and why wearables may spur creativity.
For the big mainline ad agencies, the recent creative consolidations at Pfizer and Johnson & Johnson are a big deal, but to their medical agency subsidiaries, they mostly represent a codification of where things stood to begin with.
EMD Serono refreshed its "Birds & Bees" fertility issues awareness campaign with a Facebook page and a music video.
GlaxoSmithKline launched new commercials for Alli, in time for New Year's resolutions and holiday overeating remorse, and handed off five OTC products to Meda Pharmaceuticals.
AstraZeneca launched the first consumer TV and print ads for Seroquel XR for bipolar depression, playing on the all-consuming way in which patients experience the disease.
If you still haven't entered the MM&M Awards 2009, then you'd better move fast--today (June 5) is the final deadline for submissions.
Pfizer passed Chantix creative work to McGarryBowen, ending McCann HumanCare's contract on the smoking cessation drug, agency sources confirmed.
Wyeth Consumer Health has launched a TV and print ad campaign for Advil advising consumers that they can do more with fewer bottles of OTC pain meds clogging up their purses, thanks to "The Every Pain Reliever."
GlaxoSmithKline has signed country singer Wynonna Judd to serve as the face of its OTC weight loss drug Alli.
In a reminder that the new media world is not without its perils, Johnson & Johnson is backpedaling from a Motrin campaign about slings aimed at moms that drew arrows from the Stroller Mafia.
Dusa's ClindaReach professional ads, created by Topin & Associates, snagged three awards at the AMM's Doctors' Choice Awards luncheon.
Nine months after it pulled Chantix DTC amid concern about possible psychiatric side effects, Pfizer's tortoise and hare are back on the air with a new 90-second TV spot long on risk information.
The AMM's Doctors' Choice awards has announced 13 finalists. Winners will be announced at a luncheon on September 24.
It was a plot point on a famous episode of Seinfeld, but that was the high point for the Today Sponge in recent years. Now, 12 years after Wyeth stopped making it, a new owner is looking to relaunch the contraceptive sponge to a highly-segmented swatch of consumers with brighter packaging, print ads and a Web site.
Investment in healthcare IT stands at an all-time high. The government has spent billions to promote EHR adoption. Yet the physician wish list is a mile long, while hospitals and patients are not where they need to be. To peel back the layers of what we've all been waiting for in the Great Data Capture of the 21st Century, and to review the changes enabling the healthcare data ecosystem to coexist, MM&M presents this e-Book. Click here.
- Five things for pharma marketers to know: Tuesday, July 7
- Curious if you're a finalist in the MM&M Awards? Find out now
- Vertex's Orkambi nabs FDA approval but may face payer backlash
- Fit4D expands diabetes program with Healthfirst
- Steady Leadership, Focus on Infrastructure Expected from the FDA's "Acting" Head
What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.